Ciproximide
- CAS NO.:15518-76-0
- Empirical Formula: C11H8ClNO2
- Molecular Weight: 221.642
- SAFETY DATA SHEET (SDS)
- Update Date: 2022-12-21 16:56:50
What is Ciproximide?
The Uses of Ciproximide
Antipsychotic; antidepressant.
Synthesis Reference(s)
Journal of Medicinal Chemistry, 24, p. 481, 1981 DOI: 10.1021/jm00137a002
Safety information for Ciproximide
New Products
2-Benzyl-1,1,3,3-tetramethylisoindoline 2-Bromo-4-hydroxypyridine Dibenzoyl-L-tartaric acid Anhydrous (Resolution Reagent) 1,2,3,9-Tetrahydro-9-Methyl-4H-Carbazole-4-One Cis-Tosylate 1-(4-methoxyphenyl)-4-(4-Nitrophenyl)Piperazine (IT-1) AMINO-O-TOLYL-ACETIC ACID 4-(FMOC-AMINO)-TETRAHYDROPYRAN-4-CARBOXYLIC ACID 1-Aminocyclobutanecarboxylic Acid Hydrochloride AMINO(2-BROMOPHENYL)ACETIC ACID 3-Oxocyclobutanecarboxylic acid 6-BROMOTETRAZOLO[1,5-A]PYRIDINE DEUTERIUM OXIDE FOR NMR BENZENE-D6 PHOSPORIC ACID-D3 85 W% IN D2O TRIFLOURO ACETICACID-D METHANE SULFONIC ACID-D4 TOLUENE-D3 2,5 Dibromopyridine 3-tert-Butyl-5-bromobenzaldehyde Methyl 6-(hydroxymethyl)nicotinate 4-Bromo-3-iodoaniline 4'-(Methylmercapto)-acetophrnonone 1-(3-Chlorophenyl)-4-(3-Chloropropyl) piperazine hydrochlorideRelated products of tetrahydrofuran



![3-azabicyclo[3.1.0]hexane](https://img.chemicalbook.in/CAS/GIF/285-59-6.gif)




You may like
-
254762-66-8 AMINO(2-BROMOPHENYL)ACETIC ACID 98+View Details
254762-66-8 -
254762-66-8 AMINO(2-BROMOPHENYL)ACETIC ACID 98+View Details
254762-66-8 -
23716-23-1 98+View Details
23716-23-1 -
6-BROMOTETRAZOLO[1,5-A]PYRIDINE 98+View Details
5799-75-7 -
254762-66-8 AMINO(2-BROMOPHENYL)ACETIC ACID 98+View Details
254762-66-8 -
23716-23-1 98+View Details
23716-23-1 -
6-BROMOTETRAZOLO[1,5-A]PYRIDINE 98+View Details
5799-75-7 -
1778-09-2 4'-(Methylmercapto)-acetophrnonone 98%View Details
1778-09-2
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
